Percutaneous transhepatic stenting by wallstents of portal vein and bile duct stenoses caused by immunoblastic sarcoma in a liver transplantation

Abstract

Posttransplant lymphoproliferative disorders are infrequent tumors related to chronic immunosuppressive therapy. We present a liver transplant recipient who developed such a tumor in the porta hepatis that provoked obstruction of the entire portal triad. Treatment consisted of systemic chemotherapy, percutaneous dilatation, and placement of Wallstent endoprostheses across both biliary and portal vein stenoses. The patient died 3 weeks later of pneumonia and sepsis. At necropsy, the tumor was completely necrosed and the prostheses in both the common bile duct and the portal vein were patent.

DOI: 10.1007/BF00571537

4 Figures and Tables

Statistics

0200400'97'99'01'03'05'07'09'11'13'15'17
Citations per Year

548 Citations

Semantic Scholar estimates that this publication has 548 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Bilbao1994PercutaneousTS, title={Percutaneous transhepatic stenting by wallstents of portal vein and bile duct stenoses caused by immunoblastic sarcoma in a liver transplantation}, author={J. I. Bilbao and Manuel Ruza and Jes{\'u}s Mar{\'i}a Longo and Francisco Mansilla and Antonio Picardi and Vanessa H. de Villa and Fernando Pardo and Jes{\'u}s Javier Sola and Jorge Quiroga}, journal={CardioVascular and Interventional Radiology}, year={1994}, volume={17}, pages={210-213} }